Clariant generated double-digit sales and EBITDA growth in Q3 2022

Q3 2022: Sales increased by 27 % in local currency to CHF 1.312 billion, supported by both pricing and volume growth, EBITDA margin increased to 16.8 % versus 15.5 %.

“Our performance in the third quarter was, as anticipated, fueled by sustained pricing amidst a moderate sequential decline in raw material costs, combined with renewed momentum in Catalysis, most specifically within the Petrochemicals segment.”

Continued Strong Sales Growth in Q3 2022…
…18 % Price Contribution to Specialty Portfolio Growth